Navigation Links
RRMS in Medical News

Help at hand for RRMS patients

A revolutionary research study hints at the evidence that COPAXONE? (glatiramer acetate injection) may offer protection from axonal injury and induced neuronal metabolic recovery in patients with relapsing remitting multiple sclerosis (RRMS). // COPAXONE? (glatiramer acetate injection) is a s...

New Data Suggests Progression of Disability at Two Years Predicts Multiple Sclerosis (MS) Disability Progression at Eight Years

...an Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference in Prague, Czech Republic. The analysis involved 160 patients with rrms who received at least two years of treatment (81 placebo, 79 interferon beta-1a), in the AVONEX Phase III trial and who were re-examined eight years p...
RRMS in Medical Technology

ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis

...ibit the production of VLA-4 could significantly reduce disease activity in rrms patients as early as 8 weeks. The level of efficacy achieved by ATL/TV1102 ...target VLA-4 and therefore presents an exciting future treatment option for rrms patients." Mark Diamond, Chief Executive Officer of Antisense Therapeutic...

MediciNova Announces Positive Clinical Results From MN-166 Phase II Multiple Sclerosis Trial

...mon type of the disease, affects approximately 65% of MS patients according to a Cognos study published by Decision Resources, Inc. Most patients with rrms eventually progress to the secondary progressive (SPMS) form of the disease. MN-166 is a novel, orally administered compound being evaluated for the...

First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone Was More Cost-Effective Than Interferon Beta Therapies for Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

...lity of data demonstrating the long-term treatment outcomes of immunomodulatory therapies in MS allowed us to assess the cost-effectiveness of various rrms treatment strategies. Findings of this study indicated that of the four therapies used to manage MS and in comparison with symptom management alone, t...

Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)

...n a recent issue of Neurology. The study can be accessed at: http://www.neurology.org/cgi/content/abstract/68/12/939. "COPAXONE(R) is an established rrms therapy with more than 12 years of clinical research and experience supporting its efficacy and safety. The recently published data demonstrated that ...

Data on Higher Dose of Copaxone and Data Showing Copaxone is Most Cost Effective

...http://www.neurology.org/cgi/content/abstract/68/12/939">http://www.neurology.org/cgi/content/abstract/68/12/939 . "COPAXONE is an established rrms therapy with more than 12 years of clinical research and experience supporting its efficacy and safety. The recently published data demonstrated that ...

Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)

...bo. These data were presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, MA, April 28 - May 5, 2007. "Current rrms options are effective for the treatment of the disease, but an oral therapy such as laquinimod would represent a milestone for patients as it would pr...

Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology

...cted and analyzed through 48 weeks. About MS and rrms MS is a chronic autoimmune disease of the centra...toms and different courses of disease progression. rrms is the most common form of MS, accounting for appr...recovery from relapse is incomplete, patients with rrms gradually accumulate irreversible neurological dam...

Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology

...ted and analyzed through 48 weeks. About MS and rrms MS is a chronic autoimmune disease of the centra...toms and different courses of disease progression. rrms is the most common form of MS, accounting for appr...recovery from relapse is incomplete, patients with rrms gradually accumulate irreversible neurological dam...

Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN

...rosis has undergone a prospective, controlled, multi- year, head-to-head comparison to a recommended first-line therapy. In the trial, patients with rrms at 49 medical centers in Europe and in the U.S. were treated with alemtuzumab at one of two doses (12 or 24 mg IV per day for five days at initial tre...

Copaxone Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients

...ved at 15 months with COPAXONE(R) after brief mitoxantrone therapy was maintained with continued COPAXONE(R) at 24 months. The original study included rrms patients (n=40), ages 18-55, who had at least one Gd-enhancing lesion at the time of the screening MRI and an Expanded Disability Status Scale (EDSS) ...
Other Tags
(Date:7/13/2014)... By Serena Gordon ... -- A new type of sensor for people with ... body using saliva instead of blood, researchers report. Scientists ... successfully tested it using artificial saliva. It uses light, metal ... blood sugar. "Everybody knows that diabetics have to prick ...
(Date:7/13/2014)... York, New York (PRWEB) July 13, 2014 ... lawsuits ( http://www.transvaginalmeshlawsuithelp.com/ ) filed against Johnson ... litigation’s second bellwether trial, which is expected to get ... Order issued in the U.S. District Court, Southern District ... Conference will be held on August 7, 2014 at ...
(Date:7/13/2014)... July 13, 2014 Recently, MyDressCity.com, one ... women’s special occasion outfits, has released its new range ... the new products are available at discounted prices. Worldwide ... 2014. , In the company’s online shop, there ... of them are made with great materials. MyDressCity.com’s hot ...
(Date:7/13/2014)... A noninvasive optical imaging device developed at Cedars-Sinai ... occur in the brain and are a classic ... from investigators conducting a clinical trial in Australia. ... 15 in an oral presentation at the Alzheimer,s ... also were invited by conference organizers to participate ...
(Date:7/13/2014)... OH (PRWEB) July 13, 2014 Wright ... bellwether trial has been scheduled in July of 2015, ... Lipitor lawsuits are in the discovery process ... Richard M. Gergel is presiding over the multidistrict litigation ... filed on behalf of individuals who allege that they ...
Breaking Medicine News(10 mins):Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 3Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 2Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 3Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 4
(Date:7/11/2014)... of kidney injury related to the use of hydroxyethyl ... HES molecules, according to a report in Anesthesia ... Research Society (IARS). , The "total mass of HES ... human renal proximal tubule cells (PTCs), concludes the laboratory ... Hospital Wrzburg, Austria. Other factorssuch as differences in ...
(Date:7/11/2014)... normal circumstances, astrocytes participate in normal physiological ... exhibit therapeutic and repairing effects on brain ... found that nerve cells differentiated from adipose-derived ... viability, which produces influences on subsequent studies ... Hospital, Hebei United University, China demonstrated that ...
(Date:7/11/2014)... to study the proteins that let nerve cells send ... stumbled upon a biological tactic that may offer a ... a safe and environmentally responsible way. , Their ... one species and harmless for a closely related onesuggests ... without harming beneficial species like bees. A summary of ...
Breaking Biology News(10 mins):In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3
Other Contents